Remunix, Inc. — Form D

Remunix, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-06. The offering totals $16.0M, of which $15.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-03-06
• Form: D
• Accession: 0002014586-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $16.0M
• Amount sold: $15.7M
• Remaining: $300K
• Investors: 3
• Date of first sale: 2024-02-29
• Revenue range: Decline to Disclose
• SEC file number: 021-506855

Issuer

• Name: Remunix, Inc.
• CIK: 0002014586
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 564 FIRST AVE., NEW YORK, NY, 10016
• Phone: (443) 813-1904

Officers, directors & promoters (3)

More

• CIK 2014586 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search